Introduction
============

Many pathogenic microorganisms are characterized by an intracellular lifestyle and their ability to enter, survive, proliferate, and/or persist within cells of the infected host, therefore avoiding recognition and elimination by extracellular immune surveillance mechanisms. To achieve this, these pathogens have evolved sophisticated strategies to circumvent intracellular recognition and microbicidal processes, ultimately ensuring their survival and proliferation within the host. The Gram-negative bacterium *Francisella tularensis* is the causative agent of tularemia, a vector-borne zoonosis of the Northern Hemisphere that can affect humans and cause severe morbidity and mortality if untreated or misdiagnosed. Human tularemia is a fulminant disease that can be contracted by exposure to as few as 10 bacteria, the pneumonic form of which is the most severe (Oyston et al., [@B60]). Three subspecies of *F. tularensis*, *F. tularensis* subsp. *tularensis* (Type A), *F. tularensis* subsp. *holarctica* (Type B), and *F. tularensis* subsp. *mediasiatica* are recognized, among which strains from subspecies *tularensis* and *holarctica* can cause tularemia in humans (Oyston et al., [@B60]). Additionally, *F. novicida*, an avirulent *Francisella* species in humans that retains high virulence in rodents, has been used extensively as a surrogate model for *F. tularensis* due to lower biocontainment requirements (Baron and Nano, [@B13]; Lauriano et al., [@B46]; Santic et al., [@B77],[@B78], [@B79], [@B76]; Brotcke et al., [@B20]; de Bruin et al., [@B31]; Mohapatra et al., [@B54],[@B55], [@B57], [@B56]; Weiss et al., [@B90]; Brotcke and Monack, [@B19]; Barker et al., [@B11],[@B12]; Schmerk et al., [@B81],[@B82]; Al-Khodor and Abu Kwaik, [@B2]; Asare and Abu Kwaik, [@B6]; Asare et al., [@B7]). Essential to the development of tularemia is the bacterium\'s ability to infect and proliferate within mononuclear phagocytes, such as macrophages and dendritic cells, although this bacterium can also infect polymorphonuclear neutrophils, hepatocytes, epithelial, and endothelial cells (Oyston et al., [@B60]).

Because of the importance of its intracellular lifestyle, the interactions of *F. tularensis* with host cells have been studied thoroughly, with a particular emphasis on those with macrophages. Using a variety of *Francisella* strains, such as *F. novicida*, the attenuated *holarctica* vaccine strain LVS, or virulent strains such as SchuS4 or clinical *tularensis* isolates, and host cell models, including murine or human primary macrophages and macrophage-like cell lines, several laboratories have defined the intracellular cycle of *Francisella* (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Following phagocytic uptake, *Francisella* initially resides within a phagosome called the *Francisella*-containing phagosome (FCP) that interacts with early and late compartments of the endocytic pathway (Clemens et al., [@B27]; Santic et al., [@B77]; Checroun et al., [@B23]; Chong et al., [@B25]), prior to phagosomal membrane disruption that allows bacterial release in the macrophage cytosol (Golovliov et al., [@B38]; Clemens et al., [@B27]; Santic et al., [@B77]; Checroun et al., [@B23]; Chong et al., [@B25]; Wehrly et al., [@B89]). Once cytosolic, bacteria undergo extensive replication that culminates in the apoptotic and pyroptotic deaths of the infected cells (Lai et al., [@B44]; Lai and Sjostedt, [@B45]; Mariathasan et al., [@B51]; Santic et al., [@B80]) and/or reentry into the endocytic compartments in *Francisella*-containing vacuoles (FCV) in murine primary macrophages via an autophagy-mediated process (Checroun et al., [@B23]; Wehrly et al., [@B89]). Our current knowledge of the *Francisella* intracellular cycle indicates that this bacterium can be considered a cytosolic pathogen, yet cycles through a variety of intracellular compartments with distinct environments to ensure survival, proliferation, and eventual release. For this purpose, it has likely evolved a battery of mechanisms to subvert various host cell processes. In this review, we will focus on *Francisella*--macrophage interactions and discuss recent findings about both bacterial and host factors that contribute to the intracellular pathogenesis of this bacterium.

![**Infection cycle of *F. tularensis* Schu S4 within C57BL/6J murine bone marrow-derived macrophages (BMMs)**. BMMs were infected with Schu S4 and processed at various times post infection (pi) for immunofluorescence or transmission electron microscopy. Representative confocal and electron (TEM) micrographs of intracellular SchuS4 at 30 min, 1, 4, 8, 12, and 24 h pi, showing the early phagosomal stage, phagosomal disruption, bacterial release in the cytosol, cytosolic replication, and FCV formation. Bacteria appear in green and endosomal, LAMP-1-positive membranes appear in red. White arrowheads indicate either regions of interest in whole images or bacteria enclosed within a LAMP-1-positive compartment in insets. Black arrows in TEM micrographs indicate single or double membranes surrounding intracellular bacteria. Scale bars, 10 and 2 μm (confocal images) or 0.5 μm (TEM images). Reproduced with permission from John Wiley and Sons Publishing.](fmicb-01-00138-g001){#F1}

![**Model of the *Francisella* intracellular cycle in macrophages**. Upon phagocytosis, bacteria reside in an early phagosome (FCP) that interacts with early (EE) and late (LE) endocytic compartments but not lysosomes (Lys). Bacteria rapidly disrupt the FCP membrane and reach the cytosol where they undergo extensive replication, a process followed by cell death and bacterial release or reentry of cytosolic bacteria within *Francisella*-containing vacuoles (FCV) via autophagy in murine macrophages.](fmicb-01-00138-g002){#F2}

Entry into Mammalian Cells
==========================

An essential step in the lifestyle of intracellular pathogens is binding and entry into host cells where they can undergo survival and proliferation. Such interactions require engagement of receptors that triggers specific signaling cascades, phagosome maturation events, and host microbicidal responses devoted to the destruction of the microorganism (Underhill and Ozinsky, [@B88]). Thus, the mode of uptake likely impacts the intracellular fate of a given pathogen.

The underlying mechanisms that are important for the phagocytosis of *Francisella* by macrophages are beginning to be defined. Uptake of *Francisella* into macrophages is markedly enhanced by serum opsonization (Clemens et al., [@B27], [@B28]; Balagopal et al., [@B9]; Schulert and Allen, [@B83]). In an ultrastructural analysis of the entry process of a clinical *F. tularensis* subspecies *tularensis* isolate and the attenuated *Francisella* live vaccine strain (LVS) into human monocyte derived macrophages (MDMs) or THP-1 cells, Clemens et al. ([@B28])observed bacteria engulfed within asymmetric pseudopod loops, a process that was dependent on filamentous actin, serum with intact complement factor C3, and complement receptors. Several studies have also described the contribution of complement and the complement receptor CR3 in the phagocytosis of serum-opsonized *F. novicida* and LVS by human and murine macrophages, as well as human neutrophils and dendritic cells (Balagopal et al., [@B9]; Ben Nasr et al., [@B17]; Pierini, [@B66]; Schulert and Allen, [@B83]; Barker et al., [@B11]). Fcγ receptors, scavenger receptor class A (SR-A), nucleolin, and the lung surfactant protein A (SP-A) are also involved in the uptake of serum-opsonized *F. novicida* and LVS into human and murine macrophages (Balagopal et al., [@B9]; Pierini, [@B66]; Barel et al., [@B10]), yet the predominant entry pathway appears to be mediated by complement receptor CR3 (Table [2](#T2){ref-type="table"}). Although it remains to be determined whether serum opsonization of *Francisella* is important during pathogenesis *in vivo*, CR3-mediated phagocytosis may contribute to the bacterium\'s intracellular survival, since this route of uptake does not induce the macrophage oxidative burst (Underhill and Ozinsky, [@B88]) and could therefore limit antimicrobial activities by the infected cells. Compared to opsonized bacteria, phagocytosis of non-opsonized *F. novicida* and LVS by human MDMs is mediated, in part, by the mannose receptor (MR; Balagopal et al., [@B9]; Schulert and Allen, [@B83]). The contribution of this receptor was further confirmed by the enhanced entry of LVS into J774A.1 macrophage-like cells expressing the MR and human MDMs with upregulated expression of the MR (Schulert and Allen, [@B83]).

A variety of pathogens target lipid rafts for internalization into host cells to avoid intracellular degradation (Zaas et al., [@B91]). *Francisella* appears to exploit this portal of entry, since cholesterol and caveolin-1, two components of lipid rafts, are incorporated into the newly formed FCP and cholesterol-rich lipid domains are required for uptake of LVS into the murine macrophage-like cell lines J774A.1 and RAW264.7 (Tamilselvam and Daefler, [@B86]). *Francisella* may target lipid rafts via the engagement of receptors that preferentially reside within these membrane signaling platforms, such as CR3 and Fcγ receptors (Peyron et al., [@B65]; Beekman et al., [@B15]). Consistently, depletion of lipid raft-associated GPI-anchored proteins abolished LVS entry and intracellular survival, suggesting a requirement for signaling events mediated through these proteins. Intracellular signals that accompany phagocytosis of *Francisella* involve the tyrosine kinase Syk and the MAP kinase ERK pathway (Parsa et al., [@B61]). Syk was activated upon infection of RAW264.7 cells with non-opsonized *F. novicida* (Parsa et al., [@B61]). Inhibition of Syk blocked uptake of *F. novicida* whereas overexpression enhanced uptake, demonstrating the involvement of this kinase in promoting bacterial entry (Parsa et al., [@B61]). Further analysis revealed that Syk regulates the activation of ERK and PI3K/Akt pathways. Inhibition of ERK, but not the PI3K/Akt pathway, decreased phagocytosis of *F. novicida* by macrophages (Parsa et al., [@B61]). Thus, the ERK pathway appears to be important for the phagocytosis of *Francisella*, but neither the precise mechanism of ERK activation nor the phagocytic pathways initiating this signaling have been determined.

*Francisella* Intracellular Survival Strategies
===============================================

Regardless of their replication niche, most intracellular pathogens initiate their intracellular cycle within the membrane-enclosed environment of the nascent phagosome. Newly formed phagosomes typically undergo a maturation process involving sequential interactions with the endosomal--lysosomal network that progressively modify their composition into a degradative compartment (Haas, [@B41]). To survive the destructive nature of a mature phagolysosome, intracellular pathogens must either evade or withstand this hostile environment (Haas, [@B41]). Although *Francisella* disrupts its phagosome to proliferate in the macrophage cytosol, the bacterium is likely outfitted to combat the microbicidal arsenal of this compartment during its interim phagosomal stage.

Intracellular survival: inhibition of NADPH oxidase activity
------------------------------------------------------------

Among the microbicidal agents encountered by newly ingested pathogens are the reactive oxygen species (ROS) generated by NADPH oxidase complexes assembled at the nascent phagosomal membrane. NADPH oxidase assembly involves phosphorylation of cytosolic p47^phox^, which is complexed with p67^phox^ and p40^phox^, and the entire heterotrimer translocates to cell membrane sites where the gp91^phox^ and p22^phox^ subunits accumulate. Participation of a small G-protein, either Rac1 or Rac2, is also required for NADPH oxidase function (Babior, [@B8]). *Francisella* avoids this early killing mechanism by blocking NADPH oxidase activation on the newly formed FCP in human neutrophils, as well as human and murine macrophages (McCaffrey and Allen, [@B52]; Buchan et al., [@B21]; Schulert et al., [@B84]; McCaffrey et al., [@B53]; Mohapatra et al., [@B56]). Whereas virulent strains of the *tularensis* (strain Schu S4) and *holarctica* (strain 1547-57) subspecies and the attenuated *holarctica* LVS strain exclude gp91^phox^/gp22^phox^ heterodimers from FCPs and limit p47^phox^ phosphorylation (McCaffrey and Allen, [@B52]; McCaffrey et al., [@B53]), *F. novicida* appears to mainly depend upon dephosphorylation of Phox components to disrupt NADPH oxidase function (Mohapatra et al., [@B56]). Furthermore, SchuS4 and the virulent *holarctica* strain FSC200 are more resistant to killing by ROS *in vitro* than the avirulent LVS, via mechanisms independent of the catalase KatG (Lindgren et al., [@B48]). These data highlight the subtle differences in intracellular survival mechanisms used by different *Francisella* species. Additionally, *Francisella* impairs ROS production by subsequent heterologous stimulation (McCaffrey and Allen, [@B52]; Edwards et al., [@B33]; McCaffrey et al., [@B53]; Mohapatra et al., [@B56]). McCaffrey et al. ([@B53])determined that LVS does so by retaining dysfunctional NADPH oxidase complexes on the phagosomal membranes. Altogether, these studies clearly document that *Francisella* affects pre- and post-NADPH oxidase assembly mechanisms to inhibit the phagocyte respiratory burst (McCaffrey et al., [@B53]), a process that likely contributes to its survival within the FCP.

More controversial, species-specific findings have been made on the role of other *Francisella* proteins in inhibiting antimicrobial processes. An early study showed that the acid phosphatase AcpA, purified from an attenuated *F. tularensis* type A strain (ATCC6223), inhibits the oxidative burst of activated porcine neutrophils (Reilly et al., [@B73]). Consistent with this report, Mohapatra et al. ([@B56]) found that loss of AcpA function in *F. novicida* resulted in ROS production and impaired intracellular survival in human neutrophils and MDMs. Moreover, infection with a quadruple acid phosphatase deletion mutant (Δ*acpA*ΔacpBΔacpCΔhap) triggered even higher levels of oxidant generation and increased bacterial killing than infection with a Δ*acpA* mutant, illustrating the cumulative contribution of acid phosphatases to evasion of oxidative killing (Mohapatra et al., [@B56]). Contrary to the observations regarding AcpA in *F. novicida*, studies in SchuS4 revealed that AcpA activity is dispensable for inhibition of the phagocyte oxidative defense, indicating that observations made using *F. novicida* do not always apply to *F. tularensis* subspecies strains (McCaffrey et al., [@B53]). Other bacterial factors have also been implicated in impairing oxidase activation. Pyrimidine biosynthesis genes (*carA, carB*, and *pyrB*) were identified in LVS by a random transposon mutagenesis screen for factors affecting neutrophil NADPH oxidase activation (Schulert et al., [@B84]). These uracil auxotroph mutants triggered an oxidative burst in neutrophils and were killed in phagosomes containing superoxide (Schulert et al., [@B84]). Additionally, these mutant strains were unable to block subsequent neutrophil activation by heterologous stimuli; however, the effects on neutrophil activation may be due indirectly to the diminished fitness of these mutants (Schulert et al., [@B84]). Interestingly, these auxotrophic mutants did not elicit a respiratory burst in human monocytes or MDMs but were, nonetheless, unable to survive within these phagocytes (Schulert et al., [@B84]). Together, these data suggest that *Francisella* evades oxidative killing by different mechanisms in monocytes and macrophages versus neutrophils: in the former, by utilizing uptake receptors (e.g., CR3) that do not trigger an oxidative burst, and in the latter, by actively inhibiting NADPH oxidase assembly and activation (Schulert et al., [@B84]). Two *Francisella* virulence gene regulators, *fevR* and *migR*, were also shown to be required by LVS for regulating NADPH oxidase activity in neutrophils (Buchan et al., [@B21]; McCaffrey et al., [@B53]), suggesting they regulate expression of specific effector proteins. Studies in SchuS4 confirmed that *fevR* is required to block NADPH oxidase activity, but two proteins encoded by the *Francisella* pathogenicity island (FPI) affecting phagosomal escape, *iglI* and *iglJ* (see below), are not. These observations demonstrate that distinct genes within the *fevR* regulon are required for inhibiting oxidative burst and disrupting the FCP (McCaffrey et al., [@B53]). Altogether, these data indicate that *Francisella* applies a multi-factorial, multi-pronged strategy to circumvent phagocyte oxidative defenses.

Intracellular survival: bacterial escape from the *francisella*-containing phagosome
------------------------------------------------------------------------------------

Although an early study suggested that *Francisella* inhabit atypical phagosomes within rodent macrophages (Anthony et al., [@B4]), recent findings by several laboratories have established that various *Francisella* strains escape from their initial phagosome into the cytosol of human and murine primary macrophages (Golovliov et al., [@B38]; Clemens et al., [@B27]; Santic et al., [@B77]; Checroun et al., [@B23]), yet with conflicting kinetics since phagosomal escape has been shown to occur within one to several hours post infection (pi). In several ultrastructural studies, bacteria were observed in intact phagosomes until 2--4 h pi, from which point the phagosome membrane was gradually degraded and the bacteria eventually became cytosolic (Golovliov et al., [@B38]; Clemens et al., [@B27]; Lindgren et al., [@B47]; Santic et al., [@B77]; McCaffrey and Allen, [@B52]; Schulert et al., [@B84]). Other studies, using ultrastructural analysis and phagosome integrity assays based upon the delivery of anti-*Francisella* antibodies to the cytosol of infected cells, have reported more rapid escape, where the majority of bacteria are cytosolic by 1 h pi (Checroun et al., [@B23]; Santic et al., [@B79], [@B76]; Chong et al., [@B25]; Wehrly et al., [@B89]). While such variations in phagosomal escape kinetics may be a reflection of strain differences, as illustrated by side-by-side comparison of phagosomal escape kinetics of various *Francisella* strains (Chong et al., [@B25]), technical differences and differential sensitivity in assays and criteria used to assess phagosomal disruption may have also led to these different conclusions (Clemens et al., [@B27], [@B29]; Santic et al., [@B77]; Checroun et al., [@B23]; Chong et al., [@B25]). In particular, different opsonic and non-opsonic infection models used by various laboratories may have contributed to these discrepancies in the kinetics of *Francisella* phagosomal escape. A systematic analysis of how the mode of uptake affects phagosomal escape should address this question.

Prior to phagosomal escape, *Francisella* initially resides within a phagosome that interacts with early and late endocytic compartments (Clemens et al., [@B27]; Checroun et al., [@B23]; Chong et al., [@B25]; Santic et al., [@B76]; Wehrly et al., [@B89]). While the kinetics of acquisition of endosomal markers differ depending on the infection models used, confocal and electron microscopy studies have shown that nascent phagosomes containing *F. tularensis*, LVS, or *F. novicida* transiently acquire the early endosomal antigen 1 (EEA1) followed by acquisition of late endosomal markers CD63, LAMP1, LAMP2, and the Rab7 GTPase, the eventual loss of which correlates with phagosomal disruption (Golovliov et al., [@B38]; Clemens et al., [@B27]; Santic et al., [@B77], [@B76]; Checroun et al., [@B23]; Bonquist et al., [@B18]; Chong et al., [@B25]). These early trafficking events resemble those of a normal maturation process, although the FCP does not mature into a phagolysosome as it fails to acquire the acid hydrolase cathepsin D or lysosomal tracers (Anthony et al., [@B4]; Clemens et al., [@B27]; Santic et al., [@B77]; Bonquist et al., [@B18]). Whether this results from *Francisella* actively inhibiting fusion with terminal lysosomes or from the loss of phagosomal integrity during bacterial escape still remains debatable. Santic et al. ([@B78]) have proposed that the process of phagosomal escape prevents fusion with lysosomes, since a phagosomal escape-deficient, *F. novicida* mutant in the FPI gene *iglC* (see below) is delivered to a Cathepsin D-positive, lysosomal compartment. However, Bonquist et al. ([@B18]) have observed limited fusion of vacuoles containing various phagosomal escape-deficient mutants of LVS, including mutants in *iglC* and *iglD*, arguing that some inhibition of fusion with terminal lysosomes may still occur despite a lack of phagosomal escape. It is possible that phagosomes containing mutants deficient in phagosomal escape still undergo some residual phagosomal membrane alteration that, although not disruptive enough to ensure bacterial release, affects FCP maturation and lysosomal fusion. While these discrepancies could be due to differential phagosomal escape defects between the mutant strains examined, mutants in the same genes (*iglC*, *iglD*) were used in these studies, making these findings difficult to reconcile at this stage.

Phagosomal acidification, a process dependent upon the activity of the vacuolar ATPase (vATPase) pump, is critical for the fission and fusion of membranes that promote maturation and for the optimal activity of a number of microbicidal enzymes; thus, acidification is both a requirement and a consequence of phagosomal maturation (Huynh and Grinstein, [@B42]). The extent of FCP acidification and whether acidification influences *Francisella* phagosomal escape are contentious topics. In some studies FCPs harboring LVS, SchuS4, or a clinical isolate of *F. tularensis* subspecies *tularensis* in human macrophages and J774A.1 cells resisted acidification and acquired only limited amounts of the vATPase pump, suggesting that *Francisella* impairs phagosome maturation (Clemens et al., [@B27], [@B29]; Bonquist et al., [@B18]). Moreover, the efficiency of *Francisella* phagosomal escape was unaffected in the presence of a vATPase pump inhibitor (Clemens et al., [@B29]). Other studies in human and murine macrophages reported that FCPs harboring *F. novicida* or SchuS4 became acidified and acquired the vATPase pump (Chong et al., [@B25]; Santic et al., [@B76]) prior to phagosomal disruption. Inhibition of phagosome acidification significantly delayed, but did not block, phagosomal disruption, indicating that FCP maturation is important for optimal bacterial escape to the cytosol (Chong et al., [@B25]; Santic et al., [@B76]). These studies suggest that the FCP acidic pH may provide conditions that induce and/or activate factors that promote the phagosomal disruption process, some of which may be related to pH-dependent, phagosomal iron availability (Fortier et al., [@B34]), although this needs to be formally demonstrated. Interestingly, studies reporting a lack of FCP acidification were performed using serum-opsonized bacteria, while those reporting transient FCP acidification were performed using non-opsonic conditions, regardless of the bacterial strains used, suggesting that the mode of uptake may affect FCP maturation.

Determinants of Intracellular Survival -- The *Francisella* Pathogenicity Island
================================================================================

Phagosomal escape is an essential aspect of the intracellular survival strategy of *Francisella*, since it is a process conserved among all *Francisella* strains studied to date and is a pre-requisite for cytosolic replication. Mutants impaired in phagosomal escape are defective for intracellular growth (Lindgren et al., [@B47]; Santic et al., [@B78]; Bonquist et al., [@B18]; Schmerk et al., [@B81]), and delaying translocation to the cytosol impedes the onset of replication (Chong et al., [@B25]). Thus, considerable effort has focused on determining the factors that contribute to phagosomal disruption. Several genes encoded within the FPI, an approximately 30 kb locus of 17 genes with similarity to components of the recently described type VI secretion system of *Vibrio cholera* and *Pseudomonas aeruginosa* (Mougous et al., [@B58]; Pukatzki et al., [@B68]), are involved in the phagosomal escape and intracellular survival of *Francisella* (Nano et al., [@B59]) (Table [1](#T1){ref-type="table"}). Two identical copies of the FPI are present in the genomes of *F. tularensis* subsp. *tularensis* and subsp. *holarctica* and a single copy is present in *F. novicida* (Nano et al., [@B59]), although whether FPI copy number is a factor in the virulence differences between *Francisella* species remains unclear. The FPI-encoded gene *iglC* encodes a 23-kDa hypothetical protein that is prominently induced during the intracellular growth of LVS in J774A.1 cells (Golovliov et al., [@B39]) and SchuS4 in primary bone marrow-derived macrophages (BMMs; Wehrly et al., [@B89]). Disruption of *iglC* in LVS and *F. novicida* impairs phagosomal escape and intracellular growth (Lindgren et al., [@B47]; Santic et al., [@B78]; Bonquist et al., [@B18]; Chong et al., [@B25]). In LVS, this defect was partially reversed by *in trans* complementation. In *F. novicida*, phagosomal escape was restored only with the expression of both IglC and IglD in the *iglC* mutant due to the polar effect of the mutation on IglD expression (Chong et al., [@B25]). Therefore, observations drawn from the use of this *F. novicida* mutant regarding the role of IglC (Santic et al., [@B78]) need to be re-evaluated in the absence of genetic complementation. In addition, disruption of IglCD functions significantly reduced, but did not completely block, FCP disruption, indicating the contribution of additional factors in the phagosomal escape of *Francisella* (Chong et al., [@B25]). In J774A.1 cells, the *iglD* mutant of LVS demonstrated an increased and persistent propensity for colocalization with the late endosomal marker LAMP-1 which was reversed by complementation with *iglD*, indicating that IglD function is required for escape from the FCP (Bonquist et al., [@B18]). Contradictory to this observation, Santic et al. ([@B79]) reported that the *iglD* mutant of *F. novicida* rapidly escaped into the cytosol but was unable to replicate, suggesting that IglD does not play a role in phagosomal disruption but is required for cytosolic proliferation. The distinct *iglD* mutant trafficking phenotypes reported may be a result of methodological and strain differences. It is however difficult to envision how highly conserved genes within a major virulence locus such as the FPI can have different functions between *Francisella* species. Additional mutagenesis studies in *F. novicida* have identified other FPI proteins required for intracellular survival: PdpA (Schmerk et al., [@B81]), VgrG (Barker et al., [@B12]), and IglI (Barker et al., [@B12]) are required for phagosomal escape and intramacrophage growth; *iglA* (de Bruin et al., [@B31]), *iglB* (Gray et al., [@B40]), *pdpB* (Brotcke et al., [@B20]; Tempel et al., [@B87]), and *cds2* (Brotcke et al., [@B20]) are also required for intramacrophage growth, although their contributions to intracellular trafficking have not been examined. Despite the lack of information regarding the precise functions of the FPI genes, these data highlight the importance of the FPI-encoded proteins in the intracellular pathogenesis of *Francisella*.

###### 

**Bacterial factors that contribute to the *Francisella* intracellular cycle**.

  Intracellular stage     Bacterial factors                                                                                                                           Proposed function                           References
  ----------------------- ------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------- ---------------------------------------------------------------------------------------------------
  Phagosomal escape       *iglC*                                                                                                                                      Unknown                                     Lindgren et al. ([@B47]), Santic et al. ([@B78]), Bonquist et al. ([@B18]), Chong et al. ([@B25])
                          *iglD*[^a^](#tfn1){ref-type="fn"}                                                                                                           Unknown                                     Bonquist et al. ([@B18])
                          *pdpA*                                                                                                                                      Unknown                                     Schmerk et al. ([@B81])
                          *iglI*                                                                                                                                      Unknown                                     Barker et al. ([@B12])
                          *vgrG*                                                                                                                                      Unknown                                     Barker et al. ([@B12])
                          *mglA*                                                                                                                                      Transcriptional regulator                   Baron and Nano ([@B13]), Santic et al. ([@B78]), Bonquist et al. ([@B18])
                          *fevR*                                                                                                                                      Transcriptional regulator                   Brotcke and Monack ([@B19]), Buchan et al. ([@B21]), Wehrly et al. ([@B89])
                          *migR*                                                                                                                                      Transcriptional regulator                   Buchan et al. ([@B21])
                          FTT1103                                                                                                                                     Unknown                                     Qin and Mann ([@B69]), Qin et al. ([@B71])
                          FTT1676                                                                                                                                     Unknown                                     Wehrly et al. ([@B89])
                          *carA, carB, pyrB*                                                                                                                          Uracil biosynthesis                         Schulert et al. ([@B84])
                          *acpA*[^a^](#tfn1){ref-type="fn"}, *acpB*[^a^](#tfn1){ref-type="fn"}, *acpC*[^a^](#tfn1){ref-type="fn"}, *Hap*[^a^](#tfn1){ref-type="fn"}   Acid phosphatases                           Baron et al. ([@B14]), Mohapatra et al. ([@B54], [@B57]), Child et al. ([@B24])
  Cytosolic replication   *iglD*[^a^](#tfn1){ref-type="fn"}                                                                                                           Unknown                                     Santic et al. ([@B79])
                          FTT0369c                                                                                                                                    Unknown                                     Wehrly et al. ([@B89])
                          *purMCD*                                                                                                                                    Purine biosynthesis                         Pechous et al. ([@B63], [@B64])
                          *ggt*                                                                                                                                       γ-Glutamyl transpeptidase                   Alkhuder et al. ([@B3])
                          FTT0989[^a^](#tfn1){ref-type="fn"}                                                                                                          Unknown                                     Brotcke et al. ([@B20]), Wehrly et al. ([@B89])
                          *ripA*                                                                                                                                      Unknown                                     Fuller et al. ([@B36])
                          *htpG*[^b^](#tfn2){ref-type="fn"}                                                                                                           Chaperone                                   Tempel et al. ([@B87]), Weiss et al. ([@B90])
                          *dsbB*[^b^](#tfn2){ref-type="fn"}                                                                                                           Disulfide bond formation                    Maier et al. ([@B50]), Tempel et al. ([@B87]), Weiss et al. ([@B90]), Qin et al. ([@B70])
                          *iglA*[^b^](#tfn2){ref-type="fn"}                                                                                                           Unknown                                     de Bruin et al. ([@B31])
                          *iglB*[^b^](#tfn2){ref-type="fn"}                                                                                                           Unknown                                     Gray et al. ([@B40])
                          *pdpB*[^b^](#tfn2){ref-type="fn"}                                                                                                           Unknown                                     Brotcke et al. ([@B20]), Tempel et al. ([@B87])
                          *cds2*[^b^](#tfn2){ref-type="fn"}                                                                                                           Unknown                                     Brotcke et al. ([@B20])
                          *mglB*[^b^](#tfn2){ref-type="fn"}                                                                                                           Transcriptional regulator                   Baron and Nano ([@B13])
                          *pmrA*[^b^](#tfn2){ref-type="fn"}                                                                                                           Orphaned two-component response regulator   Mohapatra et al. ([@B55]), Bell et al. ([@B16])

^a^*Contradictory findings obtained*.

^b^*Role in phagosomal escape not examined*.

Other Bacterial Determinants of Intracellular Survival
======================================================

While the FPI is to date the most prominent virulence locus required for phagosomal escape, intracellular survival and growth of *Francisella*, other proteins encoded outside the FPI have also been implicated in the proper translocation of *Francisella* into the cytosol and subsequent replication. Intracellular trafficking and survival defects of mutants in the transcriptional regulators *mglA* (Baron and Nano, [@B13]; Santic et al., [@B78]; Bonquist et al., [@B18]), *fevR* (Brotcke and Monack, [@B19]; Buchan et al., [@B21]; Wehrly et al., [@B89]), and *migR* (Buchan et al., [@B21]) have been documented. These are likely a result of the dysregulation of effector proteins that contribute to phagosomal escape and cytosolic proliferation, rather than a direct participation, since these transcription factors regulate virulence genes both within and outside of the FPI (Brotcke et al., [@B20]; Brotcke and Monack, [@B19]). Other loci, such as FTT1103 (Qin et al., [@B71]) and FTT1676 (Wehrly et al., [@B89]), both encoding hypothetical lipoproteins, are required for the phagosomal escape of SchuS4 in J774A.1 cells and murine BMMs, respectively. Three genes involved in pyrimidine biosynthesis, *carA, carB*, and *pyrB*, were identified in LVS to also play a role in phagosome disruption in human MDMs (Schulert et al., [@B84]), although their mechanistic contribution to phagosomal escape is elusive and may be indirect.

The contribution of acid phosphatases to the intracellular pathogenesis of *Francisella* has been a subject of much investigation and remains controversial. *Francisella* spp. contain at least six acid phosphatase-encoding genes, the conservation of which varies depending on the *Francisella* species (Child et al., [@B24]). While the most conserved genes are *acpA*, *acpB*, and *acpC*, others have been disrupted through genome rearrangements in virulent Type A and Type B strains, raising the question of their importance for *Francisella* virulence (Child et al., [@B24]). An *acpA* truncation mutant in *F. novicida*, lacking phosphatase activity but retaining phospholipase activity, was found to exhibit wild-type level replication in J774A.1 cells (Baron et al., [@B14]), indicating it is not essential to intracellular growth. Citing differences in mutant constructs, Mohapatra et al. ([@B54]) found that deletion of the entire *acpA* gene in *F. novicida* resulted in bacteria that were impaired for phagosomal escape and intracellular growth in human MDM and THP-1 macrophages. These defects were more pronounced with the accumulation of *acp* deletions (*acpA, acpB, acpC*, and *hapA*) indicating a cumulative role for these proteins (Mohapatra et al., [@B57]). In *F. tularensis* subspecies *tularensis*, however, neither the deletion of *acpA* nor the combined deletion of *acpA, acpB*, and *acpC* had an effect on the phagosomal escape or cytosolic proliferation in murine BMMs or human MDMs (Child et al., [@B24]). These contradictory findings between *F. novicida* and *F. tularensis* may illustrate species-specific differences. Yet, one would expect that proteins involved in an essential virulence process such as phagosomal escape to be highly conserved and not subjected to evolutionary genome reduction. While these functional differences require future clarification, they emphasize again that observations made from less virulent strains do not necessarily reflect those from virulent *F. tularensis* subspecies.

Our current knowledge of bacterial factors required for phagosomal escape indicates that it is a multi-factorial process. Consistently, a recent genetic screen performed in human macrophages using a *F. novicida* transposon mutant library identified 91 genes, encoding a variety of functions, as required for phagosomal escape (Asare and Abu Kwaik, [@B6]). Despite progress in identifying the factors involved in this crucial stage of *Francisella* trafficking, the actual mechanism of phagosome membrane disruption remains elusive and effector proteins of phagosomal disruption have yet to be characterized at the functional level.

Intracellular Replication of *Francisella*
==========================================

Besides the importance of phagosomal escape, another critical aspect of *Francisella* intracellular pathogenesis is its ability to proliferate extensively within the cytosol of host cells (Oyston et al., [@B60]). Because phagosomal escape is pre-requisite to cytosolic proliferation, the identification of factors specifically required for cytosolic proliferation using mutagenesis approaches has been challenging. Since phagosomal escape-deficient mutants are also affected in intracellular growth, assigning a specific role in cytosolic replication to a gene requires characterization of the intracellular trafficking of the corresponding mutant. A vast number of genes affecting the intracellular survival and proliferation of *Francisella* has indeed been identified through mutagenesis studies (Brotcke et al., [@B20]; Qin and Mann, [@B69]; Tempel et al., [@B87]; Su et al., [@B85]; Weiss et al., [@B90]; Alkhuder et al., [@B3]; Schulert et al., [@B84]; Wehrly et al., [@B89]; Asare and Abu Kwaik, [@B6]). Yet, few have been confirmed by targeted mutagenesis, and even fewer have been characterized and specifically implicated in cytosolic replication. Alternative approaches, such as transcriptional profiling of intracellular *Francisella*, have also revealed genetic determinants of intracellular survival based on their upregulation during the intracellular cycle (Wehrly et al., [@B89]). What has emerged from this wealth of data suggests that *Francisella* uses specific mechanisms to successfully adapt to its intracellular lifestyle, because many candidate virulence determinants encode hypothetical proteins of unknown function. Highlighted here are the determinants for which a contribution to intracellular replication has been confirmed via targeted mutagenesis, or specifically demonstrated.

Bacterial factors implicated in the intramacrophage growth of *Francisella* that have been confirmed by targeted mutagenesis studies include *pmrA* (Mohapatra et al., [@B55]; Sammons-Jackson et al., [@B75]), FTT0989 (Brotcke et al., [@B20]), *htpG* (Tempel et al., [@B87]; Weiss et al., [@B90]), *dsbB* (Maier et al., [@B50]; Tempel et al., [@B87]; Weiss et al., [@B90]; Qin et al., [@B70]), *iglD* (Santic et al., [@B79]), *iglA* (de Bruin et al., [@B31]), *iglB* (Gray et al., [@B40]), *pdpB* (Brotcke et al., [@B20]; Tempel et al., [@B87]), *cds2* (Brotcke et al., [@B20]), and *mglB* (Baron and Nano, [@B13])(Table [1](#T1){ref-type="table"}). While the role of FPI genes, such as *iglD*, *iglA*, *iglB*, *pdpB*, and *cds2*, has been discussed above with regard to phagosomal escape, the specific roles in cytosolic replication of the transcriptional regulators PmrA (Mohapatra et al., [@B55]; Sammons-Jackson et al., [@B75]) and MglB (Baron and Nano, [@B13]), the stress response protein HtpG (Tempel et al., [@B87]; Weiss et al., [@B90]), the inner membrane disulfide bond forming protein DsbB (Maier et al., [@B50]; Tempel et al., [@B87]; Weiss et al., [@B90]; Qin et al., [@B70]) and the putative transglutaminase FTT0989 (Brotcke et al., [@B20]) remain speculative until intracellular trafficking studies of the mutants are performed. The roles of these genes in intracellular growth may indeed be an indirect or non-specific consequence of their contribution to other aspects of the bacterium\'s intracellular adaptation.

More extensive studies have nonetheless identified genes required for cytosolic proliferation of *Francisella*. Characterization of purine auxotroph mutants (Δ*purMCD*) in LVS and SchuS4 revealed no defects in phagosomal escape, but bacteria failed to replicate in the cytosol of J774A.1 or primary murine macrophages (Pechous et al., [@B63], [@B64]), indicating that *Francisella* cannot scavenge nucleotides from the macrophage and must synthesize them. Another metabolism-related gene, *ggt*, encoding a γ-glutamyl transpeptidase, was identified using an *in vitro* negative screen of a library of LVS transposon mutants (Alkhuder et al., [@B3]). Disruption of *ggt* in LVS impaired cytosolic replication in murine J774A.1, RAW264.7, BMMs, and human THP-1 macrophages. Although the efficiency of escape was not thoroughly investigated, *ggt* mutant bacteria were observed in the cytoplasm of infected RAW264.7 cells at 24 h pi by ultrastructural analysis, suggesting that mutant bacteria were able to breach the FCP. Further characterization showed that *ggt* is required for bacterial acquisition of cysteine from glutathione (the most abundant source of this amino acid in the cytosol) and γ-glutamyl peptides to promote intracellular growth in murine macrophages (Alkhuder et al., [@B3]). Consistently, genes involved in the catabolism of amino acids and encoding small peptide transporters are upregulated intracellularly in SchuS4, further indicating nutrient requirements and source for cytosolic *Francisella* (Wehrly et al., [@B89]). The contribution of *ripA*, which encodes an inner membrane protein, to the intracellular growth of LVS was identified through random mutagenesis and confirmed by characterization of a targeted deletion mutant (Fuller et al., [@B36]). Δ*ripA* mutants escaped from their phagosomes with similar efficiency to wild-type LVS, but were unable to replicate in murine lung epithelial cells, TC-1, or J774A.1 cells (Fuller et al., [@B36]). The expression of *ripA* was upregulated during the early cytosolic replication stage during infection of J774A.1 macrophages, corroborating its role at this stage of the *Francisella* intracellular cycle (Fuller et al., [@B37]). Lacking homology to any previously characterized genes, the function of this *Francisella* specific factor remains to be uncovered. The FTT0369c locus, encoding a hypothetical protein with Sel1-family tetratricopeptide (TPR) repeat domains, was identified as transcriptionally upregulated during the cytosolic stage of SchuS4 infection of murine BMMs (Wehrly et al., [@B89]). Upon deletion of FTT0369c, SchuS4 bacteria were not able to replicate in the cytosol of murine BMMs, but retained phagosomal escape kinetics similar to wild-type SchuS4 (Wehrly et al., [@B89]), indicating a specific role of this locus in cytosolic proliferation.

As accentuated by the short list of determinants discussed above, characterization of the exact functions of bacterial factors specifically required for cytosolic proliferation has only just begun.

Host Factors Affecting *Francisella* Intracellular Survival
===========================================================

Understanding *Francisella*--macrophage interactions not only requires the characterization of the bacterial determinants but also that of host factors that either contribute to, or interfere with, the bacterium\'s intracellular cycle (Table [2](#T2){ref-type="table"}). Despite its ability to survive and proficiently replicate within quiescent macrophages, *Francisella* is unable to do so within interferon (IFN)-γ-activated macrophages (Anthony et al., [@B5]; Fortier et al., [@B35]; Polsinelli et al., [@B67]), indicating that host innate immune responses are capable of antagonizing *Francisella* intracellular proliferation. However, the mechanisms induced by this cytokine to control infection by *Francisella* are unclear. Several studies have ascribed the killing of LVS in IFN-γ-activated murine peritoneal exudates cells (PECs) to the actions of the inducible nitric oxide (NO) synthase (iNOS), which generates reactive nitrogen species (RNS; Anthony et al., [@B5]; Fortier et al., [@B35]; Lindgren et al., [@B49], [@B48]). In IFN-γ-activated murine alveolar macrophages, NO was determined to play a minimal role in inhibiting the intracellular growth of LVS (Polsinelli et al., [@B67]). Addition of superoxide dismutase, catalase, excess iron or [L]{.smallcaps}-tryptophan did not reverse the growth inhibition of LVS observed in IFN-γ-activated alveolar macrophages, indicating that the antibacterial activity was not mediated by ROS or limiting concentrations of l-tryptophan or iron (Polsinelli et al., [@B67]). Similar to LVS, control of SchuS4 replication in IFN-γ-activated human and murine macrophages did not involve ROS, l-tryptophan sequestration or iron limitation, nor did it seem to involve autophagy (Edwards et al., [@B33]). In studies using SchuS4, the restriction on bacterial growth was reported to be iNOS-dependent in murine PECs (Lindgren et al., [@B48]), but was iNOS-independent in primary human and murine macrophages (Edwards et al., [@B33]).

###### 

**Host factors that contribute to the *Francisella* intracellular cycle**.

  Intracellular stage     Host factors                  Function                                                                              References
  ----------------------- ----------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Entry                   Complement component C3       Activation of the complement system                                                   Clemens et al. ([@B28]), Ben Nasr et al. ([@B17]), Barker et al. ([@B11])
                          Surfactant protein A (SR-A)   Immunomodulatory pulmonary surfactant                                                 Balagopal et al. ([@B9])
                          Complement receptor 3 (CR3)   Receptor for complement component C3, facilitate phagocytosis                         Clemens et al. ([@B28]), Balagopal et al. ([@B9]), Ben Nasr et al. ([@B17]), Pierini ([@B66]), Clemens and Horwitz ([@B26]), Barker et al. ([@B11])
                          FcγR                          Receptor for antibody Fc region, facilitates phagocytosis                             Balagopal et al. ([@B9])
                          Scavenger receptor A (SR-A)   Pattern recognition receptor, facilitates phagocytosis                                Pierini ([@B66])
                          Mannose receptor (MR)         Pattern recognition receptor, facilitates phagocytosis                                Balagopal et al. ([@B9]), Schulert and Allen ([@B83])
                          Nucleolin                     Ribosome biogenesis                                                                   Barel et al. ([@B10])
                          Syk                           Signaling tyrosine kinase                                                             Parsa et al. ([@B61])
                          ERK                           Extracellular signal-regulated kinase                                                 Parsa et al. ([@B61])
  Phagosomal escape       CDC27                         Ubiquitin ligase                                                                      Akimana et al. ([@B1])
                          Akt                           Serine/threonine protein kinase                                                       Rajaram et al. ([@B72])
                          SHIP                          Inositol 5′ phosphatase                                                               Rajaram et al. ([@B72])
  Cytosolic replication   IFNγ                          Immunomodulatory and immunostimulatory cytokine                                       Anthony et al. ([@B5]), Fortier et al. ([@B35]), Polsinelli et al. ([@B67]), Lindgren et al. ([@B47], [@B49], [@B48]), Santic et al. ([@B77]), Bonquist et al. ([@B18]), Edwards et al. ([@B33])
                          PI4KCA                        Phosphatidylinositol 4 kinase                                                         Akimana et al. ([@B1])
                          USP22                         Ubiquitin hydrolase                                                                   Akimana et al. ([@B1])
                          Ras                           Small GTPase activating protein, activates several intracellular signaling pathways   Al-Khodor and Abu Kwaik ([@B2])
                          SOS2                          Ras guanine nucleotide exchange factor                                                Al-Khodor and Abu Kwaik ([@B2])
                          GrB2                          Adaptor protein that regulates receptor tyrosine kinase signal transduction           Al-Khodor and Abu Kwaik ([@B2])
                          PKCα                          Serine/threonine protein kinase                                                       Al-Khodor and Abu Kwaik ([@B2])
                          PKCβ1                         Serine/threonine protein kinase                                                       Al-Khodor and Abu Kwaik ([@B2])

In examining the interactions of LVS with IFN-γ-activated PECs, Lindgren et al. ([@B47]) found that IFN-γ treatment reduced, but did not completely block, LVS escape into the macrophage cytosol. Phagosomal escape of LVS in IFN-γ-activated J774A.1 cells was however not affected, but its intracellular growth remained restricted (Bonquist et al., [@B18]). Consistent with these findings, IFN-γ treatment did not hinder phagosomal escape of SchuS4 in murine BMMs and human MDMs (Edwards et al., [@B33]). In contrast, Santic et al. ([@B77]) found that *F. novicida* is unable to escape from the FCP and is killed within phagolysosomes in IFN-γ-activated human MDMs. Altogether, these results indicate that inhibition of intracellular growth by IFN-γ is exerted at the cytosolic stage of the *F. tularensis* intracellular cycle, whereas growth restriction is determined during the phagosomal stage for *F. novicida*. Thus, the IFN-γ-induced mechanisms inhibiting *Francisella* intracellular replication seem to be dependent on macrophage type, as well as the infecting strain, although one cannot exclude that variations in the experimental designs of these studies have yielded contrasting conclusions. Regardless, the actual effector mechanisms induced by IFN-γ remain elusive.

Alternative activation of macrophages by mast cells has been shown to effectively control the intramacrophage growth of LVS (Ketavarapu et al., [@B43]). Both contact-dependent and secreted factors from mast cells contribute to this inhibitory effect since entry and replication of LVS within murine BMMs were diminished when co-cultured with infected murine bone marrow-derived mast cells or in the presence of infected mast cell-spent media. Among the factors secreted by mast cells, IL-4 was determined to be an important component mediating bacterial growth inhibition in BMMs. An earlier report demonstrated that IL-4 mediated upregulation of MR enhanced *Francisella* uptake by macrophages (Schulert and Allen, [@B83]); this mechanism of entry may ultimately be detrimental to the intracellular survival of *Francisella* as Rodriguez et al. ([@B74]) found that restriction of intramacrophage replication by IL-4 was associated with increased ATP production, upregulated MR expression and prolonged FCP acidification, but how IL-4 affects *Francisella* intracellular fate remains to be directly demonstrated. Taken together, however, these data reflect the idea that mode of entry affects the intracellular fate of the invading pathogen.

Interactions of *Francisella* with the Autophagic Pathway
=========================================================

The cytosolic location of *Francisella* during its intracellular proliferation makes this pathogen a target for innate immune recognition and delivery to lysosomes via the autophagic pathway, a process known to recover and eliminate various cytosolic pathogens (Deretic, [@B32]). Yet, surprisingly, this bacterium can proliferate within the cytosol without any evidence for an autophagic response, suggesting it is either capable of preventing its recognition by the autophagic machinery or of inhibiting the autophagic process. Nonetheless, it was shown that a subset of cytosolic bacteria reentered the endocytic compartment in an autophagy-dependent process following replication in murine BMMs (Checroun et al., [@B23]), arguing for a belated autophagic response from the macrophage. While it remains unclear whether FCVs play a role in the intracellular cycle of *Francisella* or if they are a macrophage response to contain bacterial proliferation, their discovery indicated an involvement of autophagy in *Francisella*--macrophage interactions. Interestingly, FCV formation does not occur in human MDMs (Akimana et al., [@B1]; Edwards et al., [@B33]). While this suggests that their formation may require murine-specific signaling, one cannot exclude that higher and earlier *Francisella*-induced cytotoxicity observed in human MDMs may precede, hence prevent, FCV formation (Edwards et al., [@B33]). Additional evidence that autophagy may be manipulated by *Francisella* is that several autophagy-related genes, including *beclin1*, *ATG5*, *ATG12*, *ATG16L*, *ATG7*, and *ATG4a*, were down regulated during infection of human monocytes with SchuS4 or *F. novicida*, suggesting that *Francisella* suppresses the host autophagy response at the gene expression level (Butchar et al., [@B22]; Cremer et al., [@B30]). It was therefore proposed that by delaying autophagy, *Francisella* gains time in the macrophage cytosol to allow for replication and/or development of resistance to the acidic environment of the FCV (Cremer et al., [@B30]). However, whether autophagy is still functional in infected macrophages was not tested in these studies, so it remains to be demonstrated whether *Francisella* can actually inhibit the autophagic pathway during its intracellular cycle.

Signaling Pathways in *Francisella* Intracellular Pathogenesis
==============================================================

While innate immune processes that control *Francisella* intracellular growth have been extensively studied, additional host factors that influence the intracellular fate of *Francisella* have recently come to light from studies using *F. novicida* as a model system (Table [2](#T2){ref-type="table"}). The PI3-Kinase/Akt signaling pathway is activated early during *F. novicida* infection (Parsa et al., [@B62]; Rajaram et al., [@B72]). Although this pathway was irrelevant for the phagocytosis of *F. novicida* (Parsa et al., [@B61]), continuous activation of Akt or deletion of the inositol phosphatase SHIP, which down-regulates the PI3K/Akt pathway, inhibited phagosomal disruption, and increased FCP fusion with lysosomes in murine BMMs and RAW264.7 cells (Rajaram et al., [@B72]), suggesting that activation of this pathway is restrictive to *Francisella*. Indeed, numerous gene members of the PI3K/Akt pathway were substantially downregulated in SchuS4 and *F. novicida*-infected human monocytes (Butchar et al., [@B22]), suggesting that *Francisella* may down modulate the PI3-K/Akt pathway.

Another signaling pathway initiated by *F. novicida* involves the small G-protein Ras. Intracellular *F. novicida* transiently activated Ras within 5 min of infection of human embryonic kidney cell line HEK293T through a signaling cascade involving SOS2, Grb2, PKCα, and PKCβ1 (Al-Khodor and Abu Kwaik, [@B2]). Knockdown of these components eliminated Ras activation, and impaired *F. novicida* intracellular replication without affecting the efficiency of phagosomal escape (Al-Khodor and Abu Kwaik, [@B2]). Furthermore, silencing of these signaling molecules had no impact on the phosphorylation of Akt or ERK, indicating that Ras activation does not trigger signaling through these pathways (Al-Khodor and Abu Kwaik, [@B2]). A recent genome-wide RNAi screen was used to identify 186 host factors that influence the intracellular replication of *F. novicida* in *Drosophila melanogaster*-derived S2R+ cells (Akimana et al., [@B1]). Among these, three were confirmed by knockdown of their corresponding mammalian homologues to impact the intracellular survival of *F. novicida*. Knockdown of the ubiquitin ligase CDC27 diminished the capacity of *F. novicida* to disrupt its phagosome and to replicate in the host cytosol, while silencing of the type III PI4-kinase α subunit PI4KC and the ubiquitin specific peptidase USP22 resulted in a cytosolic replication specific defect in HEK293T cells (Akimana et al., [@B1]). These data indicate that *F. novicida* exploits multiple host signaling pathways, as well as the host ubiquitin system, to ensure its intracellular survival. Future work should examine whether these signaling pathways and host machineries are also relevant to the intracellular pathogenesis of virulent *Francisella* species.

Concluding Remarks
==================

Because the ability of *Francisella* spp. to survive and proliferate within mammalian cells is essential to their virulence, much research has focused over the last few years on understanding the intracellular cycle of these pathogens. While there is a consensus on the overall survival strategy of this pathogen, much controversy remains on more specific aspects of its intracellular cycle, such as the maturation of the FCP and the bacterial factors of phagosomal escape. Additionally, recent genomic and functional evidence indicates that caution should be exerted when assuming that conclusions drawn from studies using species of low virulence apply to virulent species of *Francisella*. A plethora of genetic screens for bacterial and host factors required for intracellular pathogenesis of various *Francisella* species has generated a wealth of information and identified key determinants of the *Francisella*--host cell interaction. Despite all these efforts, the molecular mechanisms governing the various stages of the *Francisella* intracellular cycle remain elusive. Future research on *Francisella* intracellular pathogenesis must now focus on characterizing the molecular functions of the bacterial and host factors identified, in order to gain a much-needed understanding of this bacterium\'s pathogenesis at the molecular level.
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